The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Sanofi SA

NYSE: SNY
Last

(U.S.) $45.89

Today's change-0.92 -1.97%
Updated December 19 10:07 AM EST. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $45.89

Today's change-0.92 -1.97%
Updated December 19 10:07 AM EST. Delayed by at least 15 minutes.

Sanofi SA down (U.S.)$0.92

Sanofi SA is sharply lower today, dropping (U.S.)$0.92 or 1.97% to (U.S.)$45.89. Over the last five days, shares have gained 1.62%, but sit 3.74% above the 52-week low. Shares have underperformed the S&P 500 by 25.33% during the last year.

Key company metrics

  • Open(U.S.) $46.01
  • Previous close(U.S.) $46.81
  • High(U.S.) $46.01
  • Low(U.S.) $45.57
  • Bid / Ask(U.S.) $45.86 / (U.S.) $45.89
  • YTD % change-14.43%
  • Volume372,656
  • Average volume (10-day)2,994,215
  • Average volume (1-month)2,616,278
  • Average volume (3-month)2,578,817
  • 52-week range(U.S.) $44.24 to (U.S.) $57.42
  • Beta1.03
  • Trailing P/E24.14×
  • P/E 1 year forward14.67×
  • Forward PEG3.41×
  • Indicated annual dividend(U.S.) $1.91
  • Dividend yield4.16%
  • Trailing EPS(U.S.) $1.90
Updated December 19 10:07 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.76%

Based on its net profit margin of 12.76%, Sanofi SA is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.64%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue8,8688,1467,9258,545
Total other revenue--------
Total revenue8,8688,1467,9258,545
Gross profit6,0045,5385,4095,643
Total cost of revenue2,8642,6082,5162,902
Total operating expense7,0846,9006,4977,217
Selling / general / administrative2,3092,2552,0782,148
Research & development1,1461,1881,1391,246
Depreciation / amortization561624677682
Interest expense (income), net operating--------
Unusual expense (income)15815554989
Other operating expenses, total467033-750
Operating income1,7841,2461,4281,328
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6451,1521,3871,225
Income after tax1,2648021,1131,093
Income tax, total381350274132
Net income1,1907771,0841,056
Total adjustments to net income--------
Net income before extra. items1,1907771,0841,056
Minority interest-31-27-34-39
Equity in affiliates-43252
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,1907771,0841,056
Inc. avail. to common incl. extra. items1,1907771,0841,056
Diluted net income1,1907771,0841,056
Dilution adjustment0------
Diluted weighted average shares1,3131,3151,3201,385
Diluted EPS excluding extraordinary itemsvalue per share0.910.590.820.76
Dividends per sharevalue per share0.000.000.001.30
Diluted normalized EPSvalue per share1.070.670.851.40